Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease)

Bioresorbable Stents for the Treatment of Cardiovascular Indications (coronary artery disease)
Country
Agency
Year work was carried out
Link
Details of use
Austria
LBI-HTA
2019
National Adaptation. Added executive summary in German.
Austria
GOEG
2019
Dissemination. Forwarder the report to the responsible persons in our MoH.
Croatia
AAZ
2019
Dissemination – Prepared the summary and assessment elements B0001 and A0020 in Croatian (will be published on the AAZ website along with links to the full EUnetHTA assessment).
Italy
AGENAS
2019
LINK
Translation of the report summary.
Norway
NIPHNO
Ongoing
Dissemination – Informed the National Commission Forum for Introduction of New Technologies into the Norwegian Specialist Health Care about the assessment.
Romania
NSPHMPDB
2019
Dissemination – Letter to the MoH. Link on the NSPHMPDB Facebook page.
Slovakia
UNIBA
2019
National adaptation. Updated evidence. Added impact / cost-effectiveness analysis.
Spain
SCS
2019
Dissemination – seminars and courses.
Sweden
SBU
2019
Dissemination.
United Kingdom (England)
NICE
2019
LINK
Dissemination – incorporated into NHS Evidence as a source of information for clinicians.
United Kingdom (Scotland)
SHTG
2019
.Dissemination to clinical directorate to assess level of interest in this technology in Scotland.
United Kingdom (Wales)
HTW
Ongoing
Shared with national Welsh procurement committee considering stent use. Use of HTA to be determined.